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Objectives: To analyze trends in microbiologic spectrum 
and susceptibility patterns of pathogens causing 
bacteremia in pediatric febrile neutropenic oncologic 
patients treated with two different empirical antibiotic 
regimens (ceftazidime (CAZ) plus gentamacin (GNT) 
during 1998-1999 and piperacillin/tazobactam (TAZ) 
plus GNT during 2000-2002). 
Methods: A retrospective analysis of all bacteremias 
occurring in patients with fever and neutropenia 
admitted to the Pediatric Oncology Unit between 
l/1/1998 and 281212002. 
Results: 81 bacteremia episodes were diagnosed in 40 
patients. The most common oncologic diagnoses were 
leukemia (48%) lymphoma (15%) and bone and soft 
tissue malignancies (18%). Overall, 130 (33 and 97 
during 1998-1999 and 2000-2002, respectively) organisms 
were isolated: 84 (65%) Gram negative (GmN), 39 
(30%) Gram positive (GmP) and 7 (55) fungi. Entero- 
batter spp. decreased from 18% to 6% (p=O.O5) and 
KZebsieZEa spp. increased from 9% to 15% from 
1998-1999 to 2000-2002. GmP organisms increased 
from 24% to 31% (p=O.O7) from 1998-1999 to 
2000-2002: S. epidermidis increased from 6% to 13%, 
Streptococcus spp. from 6% to 11% while S. aureus 
decreased from 6% to 0%. There were no MRSA-due 
bacteremias. 9 (21%) of the 42 E. coli, KZebsieZZu and 
Entrobacter spp isolates were resistant to all cephalo- 
sporins and to ampicillin/ clavulanate; 7/9 (78%) were 
isolated during 2000-2002. 9/9, 3/3, 3/9 (33%) and 8/9 
(89%) of these isolates were susceptible to imipenem, 
TAZ, GNT and ciprofloxacin, respectively. Overall 
pathogen susceptibility to TAZ (30 organisms tested) 
was higher compared to CAZ (76 isolates)-(94% vs. 
82%, P=O.l). 22/24 (92%) and 43/54 (78%) of GrN 
organisms isolated during 2000-2002 were susceptible to 
TAZ and CAZ, respectively (P=O.2). 
Conclusions: (1) An increase in the number of GmP 
organisms was recorded during the last 2 years; (2) An 
increase in the number of multi-drug resistant E. coli, 
KZebsieZZa and Enterobacter spp. occurred during the last 
2 years; (3) The initial empiric therapy with TAZ was 
more appropriate than CAZ in the coverage of most of 
the pathogens causing bacteremia. 
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Objective: Measurement of Incidence Laboratory 
confirmed bloodstream infection (BSI) in children with 
long-term central venous catheters (LT-CVC). 
Methods: Cohort of 745 LT-CVCs inserted in children, 
between January 1995 and July 2001, (main diagnosis, 
date of insertion, date of removal, LT-CVC type, indica- 
tion for removal) and crosslink with blood culture data 
bank (date of colection, species isolated). Any positive 
blood culture with a common pathogens (such as 
S. aureus, Gram-negative bacilli, and Cundida sp) were 
considered a catheter renal infection (CRI). Common 
skin contaminants (coagulase-negative staphylococci, 
diphtheroids, Bacillus sp., or Micrococcus sp.) isolated 
from two or more samples and associated with specific 
treatment or catheter removal, were considered a CRI. 
Results: One or more BSI episodes were observed in 
52% of LT-CVC. A total of 488 BSI episodes in 194.730 
catheters-days (2.51 episodes/l.000 CVC-days). Hickman 
or Hickman-Broviac catheters had a higher incidence of 
BSI (3.06/1000 CVC-days) when compared with Port 
catheters (1.50/1000 CVC-days; OR=2,04; PcO.05). 
Pediatric patients with hematological neoplasia, showed 
a higher BSI incidence than children with solid tumors. 
(4.88/1000 versus 1.82/1000 CVC-days, OR=2,68; 
P<0,05).The mean time to the first BSI episode was 124 
days (median=75 days). 
Conclusion: The incidence of BSI in children with LT- 
CVC varies according to the type of catheter and the 
type of neoplasia being treated. 
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Objectives: We reviewed new patient episodes of 
colonization/ infection and new episodes of bacteremia 
caused by MRSA (methicillin-resistant Staphylococcus 
aureus). We investigated the trend of incidence of MRSA 
in General Hospital Uzice. 
Methods: A total of 2255 MRSA were isolated from 
various clinical samples from January 1991 to December 
2001. 
Results: The annual rates of MRSA among S. aureus 
increased during the study period from 23.05% in 1991 
to 65.11% in 2001 (linear trend of growth, ~~0.01). The 
yield of MRSA was the highest from wounds/ulcers/skin 
swabs accounting for 83.28% while it was 1.86% from 
blood cultures. The overall incidence of colonization/ 
infection with MRSA was 1.12/100 (range 0.57-1.52) 
admissions and 0.98/1000 (range 0.50-1.29) patient-days. 
Conclusions: The incidence of MRSA in our hospital is 
high, average 42.75% and has linear trend of growth. 
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Ceftazidime resistance (CTZR) among GNB is in- 
creasing in hospitals worldwide and may be a marker for 
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cross-resistance to other antibiotic classes. CTZR may 
be due to AmpC or extended spectrum P-lactamases 
(ESBL). ESBL (+) GNB have been noted with in- 
creasing frequency in acute care and in outbreaks in NH. 
In our NH from 1995-97, rates of CTZR in clinical 
isolates were 10%. From ll/OO-3/02, screening of 1042 
GNB clinical isolates from our attached hospital yielded 
(8%) CTZR and 21 (2%) ESBL (+) isolates. Little is 
known about endemic colonization rates with CTZR 
GNB or ESBL in NH. Admissions to our NH were 
prospectively screened for GNB, CTZR, and ESBL 
every 2 weeks. Oropharynx, perineum, and wounds 
swabs were plated on MacConkey (Mac) agar. GNB 
were screened for CTZR on Mac+CTZ agar. Rectal 
swabs were plated directly on Mac+CTZ agar. CTZR 
GNB were screened for ESBL by double disk diffusion 
using CTZ or cefotaxime alone or in combination with 
clavulanate. 65 patients (pts) were screened on multiple 
occasions. 87 GNB isolates were detected in 38 pt (58%). 
GNB were found more often in pts with wounds, 
p=O.O5. Perineum (82%) and oropharynx (32%) were 
the most common sites of GNB colonization. Escherichia 
coli, Pseudomonas, Klebsiella, Proteus, Enterobacter, and 
Citrobacter were the most common genera isolated. 13 
(20%) of colonized pt had CTZR GNB, most commonly 
Pseudomonas or Enterobacter. Four pt (6%) had an 
ESBL (+) strain. No association with GNB, CTZR, or 
ESBL carriage could be made with age, declining func- 
tional status, increased length of stay, presence of devices, 
or co-morbid illness. Rates of colonization with ESBL 
producing CTZR GNB in NH may approach rates 
described in hospitals. 
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Background: Carbapenems and quinolones have a 
broad spectrum of antibacterial activity, and they are 
most potent agents used for chemotherapy of infectious 
disease caused by Gram-negative rods. Recently, how- 
ever, the emergence of the multidrug resistant Pseudo- 
monas aeruginosa (MDRP) is of utmost clinical concern, 
little information in regard to the distribution of MDRP 
in hospitals and the clinical characteristics of infected 
patients is available. To address this, we reviewed 
retrospectively the clinical charts of the patients infected 
with MDRP to clarify their clinical characteristics and 
significance in the hematological ward and screened the 
resistance gene. 
Methods: This study was conducted at Saitama Medical 
School Hospital in Saitama, Japan. We examined the 
antimicrobial susceptibilities of clinical isolates of 
MDRP, that were resistant to imipenem, amikacin, and 
ciprofloxacin, in hematological ward between 1999 
and 2001. Then we screened for the blarMp gene, which 
produced the metallo-beta-lactamase IMP-l. 
Results: A total of 16 isolated were detected in hema- 
tological disease patient in four years. We evaluated the 
clinical characteristics of 16 patients. MDRP organisms 
were isolated from stool sample (43.8%) urinary sample 
(25.0%) and respiratory sample (12.5%). Furthermore, 
the iatrogenic risk factor were anti-neoplastic agents 
(87.5%) IVH catheter (50.0%) steroids (43.8%), 
urinary catheter (43.8%). The clinical significance of 
detected MDRP was infection (25.0%) and colonization 
(68.8%). Infection was thought to have been the possible 
cause of death in 3 patients: clinical sepsis in two patient 
and terminal pneumonia in a patient. All isolations were 
detected the bluIMp gene. 
Conclusions MDRP is much detected from admini- 
stration of anti-neoplastic patients in hematological 
ward. Infection-related death was more frequent in case 
MDRP were detected in blood samples. 
Provision of safe potable water for 
immunocompromised patients in the Leeds Teaching 
Hospitals Trust 
J. Hall,’ G. Hodgson,’ D. Lester2 K.G. Kerr’ 
‘Leeds Teaching Hospitals Trust, Leeds, UK. 2Pall Life 
Sciences Europe, Portsmouth, UK 
Background: Efforts to ensure provision of microbio- 
logically safe potable water for immunocompromised 
(IC) patients have focused on the elimination of C. 
parvum, although potable water may also contain oppor- 
tunistic pathogens such as Gram-negative environmental 
bacteria. In the UK, official guidelines advise patients 
with compromised T-cell function to drink only cooled 
boiled water (CBW). The provision of large quantities 
of CBW at one hospital in Leeds was identified as 
presenting a safety risk for health care personnel and 
safer alternatives were sought. 
Methods: A survey of provision of drinking water for IC 
patients throughout the Leeds Teaching Hospitals Trust 
was conducted. A range of options for potable water 
provision was then considered-CBW, carbonated and 
non-carbonated bottled water, sterile bottled water 
(SBW), mains water direct from the faucet (MW) and 
water filtered using commercial end-line filters (FW). 
The following criteria were examined: (1) microbio- 
logical safety, (2) end-user acceptability, (3) logistical 
considerations and (4) cost. 
Results: Marked disparities in practice were identified, 
e.g. some units that provided CBW used sterile jugs, 
whereas others did not. Other areas provided only 
MW. Provision of CBW to HIV positive patients com- 
